comparemela.com
Home
Live Updates
Vivoryon Therapeutics N.V. Reports Q1 2023 Financial Results and Highlights Operational Progress : comparemela.com
Vivoryon Therapeutics N.V. Reports Q1 2023 Financial Results and Highlights Operational Progress
Vivoryon Therapeutics N.V. Reports Q1 2023 Financial Results and Highlights Operational Progress Halle (Saale) / Munich, Germany, May 16, 2023 - Vivoryon Therapeutics N.V. (Euronext
Related Keywords
Amsterdam ,
Noord Holland ,
Netherlands ,
Germany ,
Kugan Sathiyanandarajah ,
Valeria Fisher ,
Dinnies Johannes ,
Julie Seidel ,
Ulrich Dauer ,
Morten Asser Karsdal ,
Corporate Development ,
Varoglutamstat Clinical Program ,
Company Annual ,
Trophic Communications ,
International Conference On Alzheimer ,
Highlights Operational ,
Euronext Amsterdam ,
Post Period Portfolio ,
Clinical Program ,
International Conference ,
Development Highlights ,
General Meeting ,
Reflecting Vivoryon ,
Professor Morten Asser Karsdal ,
Non Executive Board ,
Annual General ,
Annual Report ,
Gefallene Big Techs ,
Vivoryon ,
Herapeutics ,
Reports ,
023 ,
Financial ,
Results ,
Highlights ,
Perational ,
Progress ,
comparemela.com © 2020. All Rights Reserved.